Why the study?
The study was conducted to assess the incidence, risk factors, and in-hospital and short-term outcomes associated with the no-reflow phenomenon in patients undergoing PCI across various coronary artery disease presentations.
What are the incidence, risk factors, and outcomes associated with the no-reflow phenomenon in CAD patients undergoing PCI?
What are the incidence, risk factors, and outcomes associated with the no-reflow phenomenon in CAD patients undergoing PCI?
No-reflow occurs in nearly 10% of PCI patients, is driven by specific clinical and angiographic risk factors, and portends significantly worse short-term clinical outcomes.
Answers are grounded in this paper and cite their sources.
No-reflow was associated with worse PCI outcomes; hypothesis-generating and requires prospective validation before practice change.
The present study assessed incidence, risk factors, in-hospital and short-term outcomes associated with no-reflow in patients undergoing percutaneous coronary intervention (PCI) in STEMI, NSTEMI, unstable angina and stable angina. Out of 449 patients, 42 (9.3%) developed no-reflow. Hypertension, dyslipidemia, obesity and smoking were significant risk factors. There was significant association of no-reflow with left main disease, multiple stents, target lesion length≥ 20 mm and higher thrombus grade. Interestingly, 93 patients (23.4%) of normal flow had myocardial perfusion grade (MPG) of 0/1 with mortality in 9 (10%) patients. No-reflow is associated with poor in-hospital and short-term outcomes with higher incidence of death, cardiogenic shock, heart failure and MACE. Knowledge of risk factors of no-reflow portends a more meticulous approach to improve final outcomes. MPG could be better predictor of outcomes in these patients.
No takes yet. Share an insight, caveat, or question.
Rao et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: